This inventor holds 18 USPTO granted patents and 9 published patent applications and 6 EPO patents, primarily in Cancer Therapeutics. Top assignees: Schering Corporation, Osi Pharmaceuticals, Inc.. Active years: 1995-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- East Setauket, NY (US) (2009)
- Chatham, NJ (US) (2006 - 2011)
- Setauket, NY (US) (2010 - 2011)
- Maplewood, NJ (US) (1995 - 2012)
Company Filing History:
Years Active: 1995-2012
Areas of Expertise:
Title: The Innovative Mind of Jonathan A Pachter: Revolutionizing Cancer Treatment
Introduction: Jonathan A Pachter, a brilliant inventor hailing from Setauket, NY, US, has made significant contributions to the field of healthcare with a remarkable portfolio of 18 patents. His groundbreaking work in developing fully human monoclonal antibodies for cancer treatment has garnered widespread recognition in the scientific community.
Latest Patents: Among his latest patents is the "Neutralizing human anti-IGFR antibody," which features fully human, neutralizing monoclonal antibodies targeting the human Insulin-like Growth Factor Receptor-I (IGFR1). These antibodies exhibit promising potential for the treatment and prevention of cancer in patients. Additionally, Pachter's "Anti-IGFR1 antibody therapeutic combinations" patent presents innovative combinations of anti-IGFR1 antibodies with chemotherapeutic agents, offering new avenues for managing medical conditions like cancer.
Career Highlights: Pachter's illustrious career includes stints at prestigious companies such as Schering Corporation and OSI Pharmaceuticals, Inc. His expertise and creativity have been instrumental in driving forward groundbreaking research and development initiatives in the pharmaceutical industry. Pachter's dedication to advancing medical science and improving patient outcomes is truly commendable.
Collaborations: Throughout his career, Jonathan A Pachter has collaborated with esteemed professionals in the field, including his coworkers Yan Wang and Ronald J Doll. These collaborations have fostered a culture of innovation and knowledge-sharing, leading to the successful development of cutting-edge therapies and treatment modalities.
Conclusion: Jonathan A Pachter's pioneering spirit and unwavering commitment to advancing cancer treatment have solidified his position as a visionary inventor in the healthcare industry. His exceptional contributions to science and medicine underscore the importance of innovation in shaping the future of healthcare. Pachter's legacy serves as an inspiration for aspiring inventors and researchers seeking to make a meaningful impact on society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile